CG
IPCI

Cutler Group’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Cutler Group’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-180
Closed -$1K – 7527
2017
Q1 		$1K Sell
180
-1,020
-85% -$26.3K ﹤0.01% 6171
2016
Q4 		$10K Buy
+1,200
New +$33.5K ﹤0.01% 4264

Other funds holding IPCI

FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Cutler Group's IPCI Position: Q2 2017 in Review

Cutler Group sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2017, closing a stake of 210 shares — an estimated $5K sold.

Cutler Group first reported a position in IPCI in Q4 2015 and held it in 6 quarters. The position peaked at $14K in Q4 2016. 19 funds tracked by Wall St. Rank hold IPCI as of Q2 2017.

  • Cutler Group reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2017 after selling out during the quarter.
  • Cutler Group sold 210 Intellipharmaceuticals International Inc. shares in Q2 2017, an estimated $5K.
  • Cutler Group first reported a position in Intellipharmaceuticals International Inc. in Q4 2015 and held it in 6 quarters.
  • Cutler Group's Intellipharmaceuticals International Inc. position peaked at $14K in Q4 2016.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.